fda aod9604 approval status December 4, 2024 Pharmacy Compounding Advisory Committee (PCAC) Meeting AOD 9604 Peptide Therapy Victoria
Description
Melanotan II is not approved for therapeutic use but is widely used by the general public
While debates persist about its classification, whats undeniable is its discoverys profound impact in 2017
Avoid very cheap options, as high-quality peptides need advanced synthesis and testing
Useful in aging research, exploring NAD+ pathways and cell repair
